Effect of oral plaque control on postoperative pneumonia following lung cancer surgery.
Dental plaque
lung cancer
plaque control
postoperative pneumonia
surgery
Journal
Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
22
01
2020
revised:
01
04
2020
accepted:
04
04
2020
pubmed:
28
4
2020
medline:
16
3
2021
entrez:
28
4
2020
Statut:
ppublish
Résumé
There have been few studies on the relationship between oral status and postoperative pneumonia (POP) in patients with lung cancer, and whether improving their oral condition assists with a lower incidence of POP before lung cancer surgery remains controversial. This retrospective study was conducted by a stomatologist to assess the effect of controlling oral pathogenic bacteria of patients with lung cancer to prevent POP. A total of 235 patients with lung cancer who underwent lobectomy by open thoracotomy between July 2015 and December 2018 were selected and given the choice of being in the experimental or control group. A total of 122 participants in the experimental group received professional oral plaque control, and 113 participants in the control group did not receive plaque control. All clinical data of participants in both groups were retrospectively studied to determine the incidence of POP at the thirtieth day of discharge from hospital. Eight in the experimental group and six in the control group were excluded from the study. It was found that four of 114 patients suffered from POP in the experimental group (incidence = 3.51%). A total of 17 of 107 patients in the control group had pulmonary infection (incidence = 15.89%). Odds ratio was 0.19. The incidence of POP in the experimental group was significantly lower than that of the control group (P < 0.05). Professional oral plaque control is associated with a lower incidence of POP following lung cancer surgery and is therefore a favorable factor for preventing POP, and should be carried out before the surgical treatment of lung cancer. Professional oral plaque control was associated with a lower incidence of POP following lung cancer surgery, and it is recommended this should be carried out before the surgical treatment of lung cancer.
Sections du résumé
BACKGROUND
There have been few studies on the relationship between oral status and postoperative pneumonia (POP) in patients with lung cancer, and whether improving their oral condition assists with a lower incidence of POP before lung cancer surgery remains controversial. This retrospective study was conducted by a stomatologist to assess the effect of controlling oral pathogenic bacteria of patients with lung cancer to prevent POP.
METHODS
A total of 235 patients with lung cancer who underwent lobectomy by open thoracotomy between July 2015 and December 2018 were selected and given the choice of being in the experimental or control group. A total of 122 participants in the experimental group received professional oral plaque control, and 113 participants in the control group did not receive plaque control. All clinical data of participants in both groups were retrospectively studied to determine the incidence of POP at the thirtieth day of discharge from hospital.
RESULTS
Eight in the experimental group and six in the control group were excluded from the study. It was found that four of 114 patients suffered from POP in the experimental group (incidence = 3.51%). A total of 17 of 107 patients in the control group had pulmonary infection (incidence = 15.89%). Odds ratio was 0.19. The incidence of POP in the experimental group was significantly lower than that of the control group (P < 0.05).
CONCLUSIONS
Professional oral plaque control is associated with a lower incidence of POP following lung cancer surgery and is therefore a favorable factor for preventing POP, and should be carried out before the surgical treatment of lung cancer.
KEY POINTS
Professional oral plaque control was associated with a lower incidence of POP following lung cancer surgery, and it is recommended this should be carried out before the surgical treatment of lung cancer.
Identifiants
pubmed: 32339413
doi: 10.1111/1759-7714.13448
pmc: PMC7262942
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1655-1660Subventions
Organisme : Research and Development
ID : 2014GGH218014
Pays : International
Informations de copyright
© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Références
Br J Surg. 2018 Nov;105(12):1688-1696
pubmed: 30088267
Oral Dis. 2007 Nov;13(6):508-12
pubmed: 17944664
Nihon Geka Gakkai Zasshi. 2017 Mar;118(2):155-60
pubmed: 30183176
J Korean Med Sci. 2011 Aug;26(8):979-84
pubmed: 21860545
Kyobu Geka. 2016 Jan;69(1):30-4
pubmed: 26975640
Ann Periodontol. 1998 Jul;3(1):251-6
pubmed: 9722708
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Respir Med. 2015 Oct;109(10):1340-6
pubmed: 26209227
Am J Respir Crit Care Med. 2006 May 15;173(10):1161-9
pubmed: 16474029
J Periodontol. 1999 Jul;70(7):793-802
pubmed: 10440642
Microb Pathog. 2016 May;94:27-34
pubmed: 26416306
Chest. 1994 Mar;105(3):760-6
pubmed: 8131538
Kyobu Geka. 2016 Jan;69(1):25-9
pubmed: 26975639
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Oct 18;50(5):840-844
pubmed: 30337745
Ann Periodontol. 2001 Dec;6(1):78-86
pubmed: 11887474
Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):750-3
pubmed: 22419796
Ann Intern Med. 2001 Nov 20;135(10):847-57
pubmed: 11712875
Eur J Cardiothorac Surg. 2003 Feb;23(2):201-8
pubmed: 12559343
Surg Neurol Int. 2013;4:24
pubmed: 23532567
Am J Med. 1991 Sep 16;91(3B):44S-53S
pubmed: 1928191
Chest. 2000 Nov;118(5):1263-70
pubmed: 11083673
Br J Hosp Med. 1994 Feb 16-Mar 1;51(4):177-80
pubmed: 8012681
Periodontol 2000. 1998 Feb;16:80-105
pubmed: 10337306
Chest. 2005 Sep;128(3):1571-9
pubmed: 16162760
J Periodontol. 2009 Oct;80(10):1606-9
pubmed: 19792849